Angiotensin-Converting Enzyme Inhibitors (ACEI)
- PMID: 28613705
- Bookshelf ID: NBK431051
Angiotensin-Converting Enzyme Inhibitors (ACEI)
Excerpt
ACE inhibitors are medications used to treat and manage hypertension, which is a significant risk factor for coronary disease, heart failure, stroke, and a host of other cardiovascular conditions. Most cases are primary and not attributable to any specific etiology. This activity reviews the indications, contraindications, activity, adverse events, and other key elements of ACE inhibitor therapy in the clinical setting related to the essential points needed by members of an interprofessional team managing the care of patients with hypertension and its related conditions and sequelae.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Nasution SA. The use of ACE inhibitor in cardiovascular disease. Acta Med Indones. 2006 Jan-Mar;38(1):60-4. - PubMed
-
- Vidt DG, Bravo EL, Fouad FM. Drug therapy. Captopril. N Engl J Med. 1982 Jan 28;306(4):214-9. - PubMed
-
- Todd PA, Heel RC. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs. 1986 Mar;31(3):198-248. - PubMed
-
- Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? J Am Coll Cardiol. 2018 Apr 03;71(13):1474-1482. - PubMed
-
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 05;311(5):507-20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous